Sign Up to like & get
recommendations!
0
Published in 2021 at "Current cancer drug targets"
DOI: 10.2174/1568009621666210601111811
Abstract: BACKGROUND Little is known about the efficacy of programmed cell death protein-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) inhibitors in patients with central nervous system (CNS) metastases. OBJECTIVE Assess the difference in efficacy of…
read more here.
Keywords:
cns metastases;
central nervous;
efficacy;
patients cns ... See more keywords